1993
DOI: 10.1097/00008483-199305000-00014
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Shuttle Walking Test of Disability in Patients with Chronic Airways Obstruction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
275
1
13

Year Published

2004
2004
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 208 publications
(295 citation statements)
references
References 2 publications
6
275
1
13
Order By: Relevance
“…As expected, the mean (SD) ISWT distance was higher in our patients with severe asthma compared to the studies among COPD and CHF patients with moderate to severe disease (302 (133) and 380 (190) m accordingly) . However, the average ISWT distance was lower in our study population compared to adults with obstructive sleep apnoea (OSA) with obesity, cystic fibrosis (CF) and the healthy population reported in other studies (580 (207), 754 (362) and 733 (183), respectively) .…”
Section: Discussionsupporting
confidence: 62%
See 3 more Smart Citations
“…As expected, the mean (SD) ISWT distance was higher in our patients with severe asthma compared to the studies among COPD and CHF patients with moderate to severe disease (302 (133) and 380 (190) m accordingly) . However, the average ISWT distance was lower in our study population compared to adults with obstructive sleep apnoea (OSA) with obesity, cystic fibrosis (CF) and the healthy population reported in other studies (580 (207), 754 (362) and 733 (183), respectively) .…”
Section: Discussionsupporting
confidence: 62%
“…The protocol used for ISWT in the OSA and CF studies differed from other studies in that patients were allowed to run as the speed on the ISWT increased. We adhered to the original protocol for performing ISWT as described by Singh et al, where ISWT was validated with walking only. This could explain why patients with CF had a slightly higher ISWT distance compared to healthy individuals and may also explain the better performance on ISWT among patients with OSA and CF compared to the patients with severe asthma in our study.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The pace is set at 85% of the maximal pace achieved on an incremental shuttle test. The ESWT is well validated for measuring exercise capacity in COPD populations with good repeatability . In IPF and sarcoidosis patients, distance walked during ESWT correlates well with resting oxyhaemoglobin saturation on pulse oximetry (SpO 2 ), DLCO and peak VO 2 as measured with CPET .…”
Section: Tests For Investigating Exercise Performancementioning
confidence: 91%